Accelerated Pharma (Accelerated Pharma) Additional Paid-In Capital : $4.01 Mil(As of Mar. 2017)

View and export this data going back to 2016. Start your Free Trial

What is Accelerated Pharma Additional Paid-In Capital?

Accelerated Pharma's quarterly additional paid-in capital stayed the same from Sep. 2016 ($3.95 Mil) to Dec. 2016 ($3.95 Mil) but then increased from Dec. 2016 ($3.95 Mil) to Mar. 2017 ($4.01 Mil).

Accelerated Pharma's annual additional paid-in capital stayed the same from Dec. 2014 ($1.99 Mil) to Dec. 2015 ($1.99 Mil) but then increased from Dec. 2015 ($1.99 Mil) to Dec. 2016 ($3.95 Mil).

Accelerated Pharma Additional Paid-In Capital Historical Data

The historical data trend for Accelerated Pharma's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerated Pharma Additional Paid-In Capital Chart

Accelerated Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Additional Paid-In Capital

1.99

3.95

Accelerated Pharma Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Additional Paid-In Capital	Get a 7-Day Free Trial			-	3.95	3.95	3.95	4.01

Accelerated Pharma Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Accelerated Pharma Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Accelerated Pharma's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Accelerated Pharma (Accelerated Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Accelerated Pharma Inc, is a Delaware corporation organized on May 12, 2014. It is a biopharmaceutical company focused on utilizing its genomic technology to enhance the development and commercialization of pharmaceutical products. Its lead product candidate is Picoplatin, a new generation platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications.

Accelerated Pharma (Accelerated Pharma) Headlines

No Headlines